433 related articles for article (PubMed ID: 11137865)
1. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
Gur E; Dremencov E; Lerer B; Newman ME
Eur J Pharmacol; 2001 Jan; 411(1-2):115-122. PubMed ID: 11137865
[TBL] [Abstract][Full Text] [Related]
2. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively.
Newman ME; Gur E; Dremencov E; Garcia F; Lerer B; Van de Kar LD
Neuropharmacology; 2000 Sep; 39(12):2309-17. PubMed ID: 10974314
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of chronic electroconvulsive shock on serotonergic 5-HT(1A) and 5-HT(1B) receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Garcia F; Van de Kar LD; Lerer B; Newman ME
Brain Res; 2002 Oct; 952(1):52-60. PubMed ID: 12363404
[TBL] [Abstract][Full Text] [Related]
4. Subchronic fluoxetine administration to rats: effects on 5-HT autoreceptor activity as measured by in vivo microdialysis.
Dremencov E; Gur E; Lerer B; Newman ME
Eur Neuropsychopharmacol; 2000 Jul; 10(4):229-36. PubMed ID: 10871704
[TBL] [Abstract][Full Text] [Related]
5. Effects of chronically administered venlafaxine on 5-HT receptor activity in rat hippocampus and hypothalamus.
Gur E; Dremencov E; Van De Kar LD; Lerer B; Newman ME
Eur J Pharmacol; 2002 Feb; 436(1-2):57-65. PubMed ID: 11834247
[TBL] [Abstract][Full Text] [Related]
6. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
Gur E; Lifschytz T; Van De Kar LD; Lerer B; Newman ME
Psychoneuroendocrinology; 2004 Oct; 29(9):1172-83. PubMed ID: 15219641
[TBL] [Abstract][Full Text] [Related]
7. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.
Gur E; Newman ME; Avraham Y; Dremencov E; Berry EM
Nutr Neurosci; 2003 Jun; 6(3):169-75. PubMed ID: 12793521
[TBL] [Abstract][Full Text] [Related]
8. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
9. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
Yoshitake T; Yoshitake S; Yamaguchi M; Ogren SO; Kehr J
Neuropharmacology; 2003 Feb; 44(2):206-13. PubMed ID: 12623219
[TBL] [Abstract][Full Text] [Related]
10. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
Dekeyne A; Brocco M; Adhumeau A; Gobert A; Millan MJ
Psychopharmacology (Berl); 2000 Sep; 152(1):55-66. PubMed ID: 11041316
[TBL] [Abstract][Full Text] [Related]
11. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
12. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
Knobelman DA; Hen R; Blendy JA; Lucki I
J Pharmacol Exp Ther; 2001 Sep; 298(3):1092-100. PubMed ID: 11504806
[TBL] [Abstract][Full Text] [Related]
13. 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment.
Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Gadek-Michalska A; Wedzony K
Neuropsychopharmacology; 2003 Jul; 28(7):1300-10. PubMed ID: 12700680
[TBL] [Abstract][Full Text] [Related]
14. Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study.
Gur E; Lerer B; Newman ME
J Neural Transm (Vienna); 1997; 104(8-9):795-804. PubMed ID: 9451712
[TBL] [Abstract][Full Text] [Related]
15. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
16. SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue.
Watson J; Roberts C; Scott C; Kendall I; Collin L; Day NC; Harries MH; Soffin E; Davies CH; Randall AD; Heightman T; Gaster L; Wyman P; Parker C; Price GW; Middlemiss DN
Br J Pharmacol; 2001 Jul; 133(6):797-806. PubMed ID: 11454652
[TBL] [Abstract][Full Text] [Related]
17. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
18. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
Zahorodna A; Tokarski K; Bijak M
Eur J Pharmacol; 2002 May; 443(1-3):51-7. PubMed ID: 12044792
[TBL] [Abstract][Full Text] [Related]
19. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
Otano A; García-Osta A; Ballaz S; Frechilla D; Del Río J
Br J Pharmacol; 1999 Dec; 128(8):1691-8. PubMed ID: 10588924
[TBL] [Abstract][Full Text] [Related]
20. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
Assié MB; Cosi C; Koek W
Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
